neuroimaging-in-addiction-psychiatry-coverpage

Dr. Rajendra Badgaiyan, MD

Editor-in-Chief

Chairperson, Department of Psychiatry, MetroHealth System MetroHealth Dr. Cleveland, OH, USA

Dr. Kenneth Blum, PhD, DHL (Psychology)

Co-Editor-in-Chief

Department of Psychiatry, Western University College of Medicine, Pomona, CA, USA

Frequency: Bi-annual

ISSN: 3065-5889

Abstracted/Indexed in: OCLC – WorldCat, SHERPA/RoMEO, Hinari, Genamics, J-Gate, Scilit and Google Scholar

Welcome Note

The Journal of Addiction Psychiatry (JAP) welcomes researchers, psychiatrists, psychologists, clinicians, mental health professionals, and healthcare providers to contribute to a dynamic platform dedicated to advancing research and clinical practice in addiction, psychiatry, and behavioral health.

Addiction and related mental health conditions present complex challenges that require a deeper understanding of their biological, psychological, social, and clinical dimensions. JAP provides a platform for research addressing substance use disorders, behavioral addictions, co-occurring psychiatric conditions, prevention, diagnosis, treatment, recovery, and other emerging areas in addiction and mental health.

Read More
Figure 1

August 14, 2026

Trends in Cannabis Exposure and Psychosis Among U.S. Adolescents in Emergency Rooms from 2016 to 2024

Sue D. Muggar, Jaime A. Perez, Farrah Laviolette and Molly McVoy
Objectives: To utilize a retrospective observational design to characterize adolescents aged 13 – 17 presenting to emergency rooms (ER) in the United States (US) from 2016 to 2024 with psychosis and/or delta-9-tetrahydrocannabinol (THC) exposure via urine drug screens (UDS) and to evaluate trends in THC exposure, psychiatric comorbidities, and demographics.

Read More
figure 1 (3)

March 4, 2026

Reward Deficiency Syndrome: Criteria Unspecified Mental Disorder

Kenneth Blum, Kai Uwe-Lewandrowski, Richard Green, Morgan P. Lorio, Alireza Sharafshah, Kavya Mohankumar, Sergio Luis Schmidt, Rossano Kepler Alvim Fiorelli, Frank Forari, Igor Elman, Mark S. Gold, Panayotis K. Thanos, Albert Pinhasov, Abdalla Bowirrat, David Baron, Edward J. Modestino, Brian Fuehrlein, Jag Khalsa, Keerthy Sunder, Marco Lindenau, Anand Swaroop, Debasis Bagchi, Álvaro Dowling, Rafaela Dowling, João Bergamaschi, Margaret A. Madigan and Rajendra D. Badgaiyan

Reward Deficiency Syndrome (RDS) is a neurogenetically influenced phenotype marked by impaired dopaminergic signaling and mesocorticolimbic reward-circuit dysfunction, leading to reduced reward sensitivity, motivational anhedonia, heightened stress reactivity, and increased vulnerability to compulsive, impulsive, and addictive behaviors.

Read More

Scope, Aims & Topics

The Journal of Addiction Psychiatry (JAP) is a peer-reviewed, open-access journal dedicated to advancing research and clinical practice in addiction, psychiatry, and behavioral health. The journal publishes original research, reviews, case reports, perspectives, and other scholarly contributions addressing the biological, psychological, social, and clinical dimensions of addiction and mental health.

JAP aims to promote a deeper understanding of substance use disorders and related psychiatric conditions while supporting advances in prevention, diagnosis, treatment, recovery, and public health. The journal encourages interdisciplinary collaboration among clinicians, researchers, mental health professionals, and policymakers.

Read More